Shivalik Rasayan Allots 2.82 Lakh Shares And 9.48 Lakh Warrants At Rs250

Board allotted 2,82,000 equity shares at Rs250 for Rs7.05Cr to public and 9,47,990 warrants at Rs250 for Rs23.70Cr to promoter and public. Promoter Growel Remedies took 4,28,000 warrants. Fresh preferential round extends dilution-funded capex pattern; prior issues funded Dahej build. Promoter taking near half the warrants signals backing for Dahej ramp. Fully diluted shares rise to 1,69,80,355; adds equity buffer while cash conversion weak. Use of proceeds, pricing basis and warrant exercise timeline not disclosed.